Prevention of Progression in Chronic Liver Disease

Lieferzeit: Lieferbar innerhalb 14 Tagen

106,99 

An Update on SNMC (Stronger Neo-Minophagen C).In honour of Hans Popper’s 100th birthday, Falk Symposium 138A

ISBN: 0792387961
ISBN 13: 9780792387961
Herausgeber: N Hiyashi/M P Manns
Verlag: Springer Verlag GmbH
Umfang: viii, 130 S.
Erscheinungsdatum: 21.07.2004
Produktform: Gebunden/Hardback
Einband: GEB

In several liver diseases, the underlying cause cannot always be eliminated. This is true for non-responders to the treatment of chronic hepatitis C (HCV). It is relevant for more than 40 per cent of patients with HCV genotype 1 and up to 20 per cent of patients with genotype 2 or 3.

Artikelnummer: 1641448 Kategorie:

Beschreibung

InhaltsangabeList of Principal Authors. Preface. Introduction; H Suzuki. 1: Mechanisms of fibrogenesis; B Stefanovic, J Lindquist, RA Rippe, B Schnabl, R Schwabe, R Bataller, DA Brenner. 2: Non-invasive markers of liver injury; V Ratziu, T Poynard. 3: Complications of cirrhosis: the relevance of hepatocellular carcinoma; M Colombo, M Iavarone. 4: Controlling necroinflammation of liver with SNMC (Stronger Neo Minophagen C): therapy on interferon non-responders; S Lino. 5: Predictive parameters of non-response to standard hepatitis treatment; H Wedemeyer. 6: Concepts for the treatment of non-responders in hepatitis C; S Zeuzem. 7: Glycyrrhizin: the molecule and present knowledge of action in various liver diseases; K Shiraki, H Sato, M Kurokawa, Y Yoshida. 8: Dendritic cells in immune responses against hepatitis C virus; N Hayashi, T Kanto, T Takehara. 9: SNMC in the prevention of cirrhosis and hepatocellular carcinoma: Japanese experience; K Ikeda. 10: SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials; S Schalm, TGF van Rossum, H Orlent, BE Hansen. Index

Inhaltsverzeichnis

List of Principal Authors. Preface. Introduction; H Suzuki. 1: Mechanisms of fibrogenesis; B Stefanovic, J Lindquist, RA Rippe, B Schnabl, R Schwabe, R Bataller, DA Brenner. 2: Non-invasive markers of liver injury; V Ratziu, T Poynard. 3: Complications of cirrhosis: the relevance of hepatocellular carcinoma; M Colombo, M Iavarone. 4: Controlling necroinflammation of liver with SNMC (Stronger Neo Minophagen C): therapy on interferon non-responders; S Lino. 5: Predictive parameters of non-response to standard hepatitis treatment; H Wedemeyer. 6: Concepts for the treatment of non-responders in hepatitis C; S Zeuzem. 7: Glycyrrhizin: the molecule and present knowledge of action in various liver diseases; K Shiraki, H Sato, M Kurokawa, Y Yoshida. 8: Dendritic cells in immune responses against hepatitis C virus; N Hayashi, T Kanto, T Takehara. 9: SNMC in the prevention of cirrhosis and hepatocellular carcinoma: Japanese experience; K Ikeda. 10: SNMC in interferon non-responders with chronic hepatitis C: European experience in controlled trials; S Schalm, TGF van Rossum, H Orlent, BE Hansen. Index

Das könnte Ihnen auch gefallen …